Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3735-3745
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3735
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3735
Case | Age/sex | BMI (kg/m2) | Lobular inflammation | Hepatocyte ballooning | Steatosis score | Steatosis | Fibrosis | NAS score | Scores for PTEN expression | ||
NS | S | NS-S | |||||||||
Controls | |||||||||||
1 | 86/M | ND | 0 | 0 | 0 | 0% | 0 | 0 | 4 | / | / |
2 | 32/F | ND | 0 | 0 | 0 | 0% | 0 | 0 | 4 | / | / |
3 | 36/M | ND | 0 | 0 | 0 | 0% | 0 | 0 | 3 | / | / |
Pure steatosis | |||||||||||
4 | 26/M | 39 | 0 | 0 | 1 | 10% | 0 | 1 | 4 | 2 | 2 |
5 | 46/M | 43 | 0 | 0 | 1 | 30% | 0 | 1 | 3 | 2 | 1 |
6 | 38/F | 55 | 0 | 0 | 1 | 20% | 0 | 1 | 4 | 2 | 2 |
7 | 36/F | 34 | 0 | 0 | 1 | 10% | 0 | 1 | 4 | 4 | 0 |
8 | 37/F | 35 | 0 | 0 | 2 | 60% | 0 | 2 | 3 | 1 | 2 |
9 | 45/M | 54 | 0 | 0 | 2 | 50% | 0 | 2 | 4 | 1 | 3 |
10 | 29/M | 41 | 0 | 0 | 2 | 40% | 0 | 2 | 4 | 1 | 3 |
11 | 60/F | 39 | 0 | 0 | 3 | 80% | 0 | 3 | 4 | 2 | 2 |
12 | 43/M | 40 | 0 | 0 | 3 | 70% | 0 | 3 | 4 | 1 | 3 |
13 | 45/M | 42 | 0 | 0 | 3 | 70% | 0 | 3 | 4 | 1 | 3 |
Steatohepatitis without fibrosis | |||||||||||
14 | 49/F | 36 | 0 | 1 | 1 | 30% | 0 | 2 | 2 | 2 | 0 |
15 | 48/F | 58 | 0 | 1 | 2 | 50% | 0 | 3 | 4 | 1 | 3 |
16 | 57/M | 34 | 1 | 1 | 2 | 60% | 0 | 4 | 3 | 3 | 0 |
17 | 56/F | 47 | 0 | 1 | 3 | 70% | 0 | 4 | 4 | 2 | 2 |
18 | 40/M | 40 | 0 | 1 | 3 | 70% | 0 | 4 | 3 | 2 | 1 |
19 | 38/F | 45 | 1 | 2 | 3 | 80% | 0 | 6 | 3 | 1 | 2 |
20 | 59/F | 41 | 1 | 1 | 3 | 70% | 0 | 5 | 4 | 1 | 3 |
21 | 50/M | 50 | 1 | 1 | 3 | 70% | 0 | 5 | 4 | 1 | 3 |
22 | 35/F | 51 | 1 | 1 | 3 | 80% | 0 | 5 | 3 | 2 | 1 |
23 | 54/F | 44 | 1 | 1 | 2 | 50% | 0 | 4 | 3 | 2 | 1 |
24 | 42/F | 39 | 1 | 1 | 3 | 80% | 0 | 5 | 4 | 1 | 3 |
25 | 51/F | 43 | 1 | 2 | 2 | 50% | 0 | 5 | 4 | 2 | 2 |
26 | 56/M | 39 | 1 | 1 | 3 | 80% | 0 | 5 | 3 | 2 | 1 |
27 | 39/F | 40 | 1 | 1 | 3 | 70% | 0 | 5 | 3 | 2 | 1 |
Steatohepatitis with fibrosis | |||||||||||
28 | 62/M | 39 | 0 | 0 | 3 | 80% | 1a | 3 | 4 | 1 | 3 |
29 | 47/F | 47 | 0 | 0 | 2 | 50% | 1a | 2 | 4 | 1 | 3 |
30 | 21/M | 40 | 0 | 0 | 3 | 80% | 1a | 3 | 3 | 2 | 1 |
31 | 50/F | 42 | 0 | 0 | 3 | 70% | 1a | 3 | 4 | 2 | 1 |
32 | 54/M | 32 | 0 | 0 | 1 | 10% | 1a | 1 | 3 | 2 | 1 |
33 | 57/M | 51 | 0 | 0 | 2 | 50% | 1b | 2 | 4 | 1 | 3 |
34 | 60/M | 40 | 0 | 0 | 1 | 20% | 1b | 1 | 3 | 3 | 0 |
35 | 48/F | 63 | 0 | 0 | 3 | 80% | 1c | 3 | 4 | 1 | 3 |
36 | 55/M | 35 | 0 | 0 | 2 | 50% | 2 | 2 | 4 | 1 | 3 |
37 | 40/F | 45 | 0 | 0 | 3 | 70% | 2 | 3 | 2 | 1 | 1 |
38 | 36/M | 41 | 1 | 2 | 3 | 90% | 3 | 6 | 4 | 1 | 3 |
39 | 59/M | 36 | 1 | 2 | 2 | 60% | 3 | 5 | 4 | 1 | 3 |
Cirrhosis | |||||||||||
40 | 61/M | ND | 0 | 1 | 1 | 20% | 4 | 2 | 3 | 3 | 0 |
41 | 51/F | 38 | 1 | 0 | 1 | 20% | 4 | 2 | 3 | 3 | 0 |
42 | 54/M | 58 | 1 | 1 | 2 | 50% | 4 | 4 | 4 | 1 | 3 |
43 | 64/F | 35 | 3 | 2 | 1 | 20% | 4 | 6 | 3 | 2 | 1 |
44 | 60/M | 36 | 1 | 2 | 2 | 50% | 4 | 5 | 2 | 1 | 1 |
45 | 68/F | 48 | 2 | 1 | 2 | 50% | 4 | 5 | 3 | 1 | 2 |
46 | 65/F | 47 | 1 | 1 | 3 | 70% | 4 | 5 | 4 | 1 | 3 |
47 | 54/F | 42 | 2 | 1 | 3 | 70% | 4 | 6 | 4 | 1 | 3 |
Case | Age/sex | BMI (kg/m2) | Inflammation | Fibrosis | Cirrhosis | Steatosis | Score for PTEN expression | ||
NS | S | NS-S | |||||||
Non-obese patients | |||||||||
1 | 56/F | 26 | - | p | - | 100% | 3 | 2 | 1 |
2 | 49/F | 25 | - | psn | - | 40% | 4 | 3 | 1 |
3 | 59/M | 29 | + | - | + | 60% | 3 | 3 | 0 |
4 | 57/F | 27 | + | - | + | 80% | 3 | 3 | 0 |
5 | 66/M | 25 | + | - | + | 90% | 4 | 3 | 1 |
6 | 55/F | 28 | + | - | + | 90% | 3 | 3 | 0 |
7 | 61/M | 25 | + | psn | + | 70% | 4 | 4 | 0 |
8 | 43/M | 23 | + | psn | + | 80% | 4 | 3 | 1 |
9 | 36/M | 25 | + | - | + | 60% | 3 | 2 | 1 |
10 | 41/M | 24 | + | psn | + | 40% | 4 | 3 | 1 |
11 | 64/M | 21 | + | - | + | 10% | 4 | 4 | 0 |
12 | 46/F | 27 | - | - | + | 90% | 3 | 3 | 0 |
13 | 28/F | 22 | + | - | + | 80% | 4 | 4 | 0 |
14 | 51/M | 25 | - | p | + | 90% | 4 | 3 | 1 |
15 | 43/M | 20 | + | psn | + | 70% | 3 | 3 | 0 |
16 | 54/M | 20 | - | psn | + | 80% | 4 | 4 | 0 |
17 | 36/M | 23 | - | psn | + | 70% | 3 | 2 | 1 |
Obese patients | |||||||||
18 | 60/M | 30 | - | psn | - | 70% | 3 | 3 | 0 |
19 | 55/F | 41 | - | p | - | 70% | 3 | 3 | 0 |
20 | 57/M | 33 | + | - | + | 80% | 3 | 3 | 0 |
21 | 55/M | 30 | + | - | + | 70% | 3 | 2 | 1 |
22 | 51/M | 32 | - | - | + | 20% | 4 | 4 | 0 |
23 | 65/M | 31 | - | psn | + | 5% | 4 | 4 | 0 |
24 | 72/M | 34 | + | psn | + | 90% | 4 | 4 | 0 |
25 | 39/M | 31 | + | - | + | 20% | 4 | 4 | 0 |
- Citation: Sanchez-Pareja A, Clément S, Peyrou M, Spahr L, Negro F, Rubbia-Brandt L, Foti M. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease. World J Gastroenterol 2016; 22(14): 3735-3745
- URL: https://www.wjgnet.com/1007-9327/full/v22/i14/3735.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i14.3735